Exact Mass: 345.2879

Exact Mass Matches: 345.2879

Found 130 metabolites which its exact mass value is equals to given mass value 345.2879, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

Himbacine

(+)-Himbacine

C22H35NO2 (345.2668)


A piperidine alkaloid that is decahydronaphtho[2,3-c]furan-1(3H)-one substituted by a methyl group at position 3 and a 2-[(2R,6S)-1,6-dimethylpiperidin-2-yl]ethenyl group at position 4. It has been isolated from the bark of Australian magnolias. D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics relative retention time with respect to 9-anthracene Carboxylic Acid is 0.814 relative retention time with respect to 9-anthracene Carboxylic Acid is 0.809

   
   

Macamide B

N-Benzylhexadecanamide;Macamide 1

C23H39NO (345.3031)


N-benzylhexadecanamide is a macamide resulting from the formal condensation of the carboxy group of hexadecanoic acid with benzylamine. A moderate inhibitor of fatty acid amide hydrolase. It has a role as a neuroprotective agent, a plant metabolite and an EC 3.5.1.99 (fatty acid amide hydrolase) inhibitor. It is a secondary carboxamide and a macamide. It is functionally related to a hexadecanoic acid and a benzylamine. N-benzylpalmitamide is a natural product found in Lepidium meyenii with data available. See also: Lepidium meyenii root (part of). A macamide resulting from the formal condensation of the carboxy group of hexadecanoic acid with benzylamine. A moderate inhibitor of fatty acid amide hydrolase. Macamide B is found in root vegetables. Macamide B is an alkaloid from the tubers of Lepidium meyenii (maca). Alkaloid from the tubers of Lepidium meyenii (maca). Macamide B is found in root vegetables. Macamide B (N-Benzylhexadecanamide; Macamide 1) is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH). N-Benzylpalmitamide is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH). N-Benzylpalmitamide is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH).

   

2,4,12-Octadecatrienoic acid piperidide

(2E,4Z,12E)-1-(piperidin-1-yl)octadeca-2,4,12-trien-1-one

C23H39NO (345.3031)


2,4,12-Octadecatrienoic acid piperidide is an alkaloid from Piper retrofractum (Javanese long pepper

   

Eicosapentaenoyl Ethanolamide

(5Z,8Z,11Z,14Z,17Z)-N-(2-hydroxyethyl)icosa-5,8,11,14,17-pentaenamide

C22H35NO2 (345.2668)


Eicosapentaenoyl Ethanolamide (EPEA) is an endogenous fatty acid amide. EPEA is metabolized by fatty acid amide hydrolase (FAAH) and N-acylethanolamine-hydrolyzing acid amidase (NAAA), the latter of which has more specificity toward PEA over other fatty acid amides. DHEA and eicosapentaenoyl ethanolamide (EPEA) bind to the CB1 receptor in rat brains.23 DHA levels in the mouse brain have been shown to inversely affect the levels of 2AG. Eicosapentaenoyl Ethanolamide (EPEA) is an endogenous fatty acid amide.

   

3-hydroxyundecanoyl carnitine

3-[(3-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


3-Hydroxyundecanoyl carnitine is an acylcarnitine. More specifically, it is an 3-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 3-Hydroxyundecanoyl carnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 3-hydroxyundecanoyl carnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

8-Hydroxyundecanoylcarnitine

3-[(8-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


8-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 8-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 8-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 8-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Hydroxyundecanoylcarnitine

3-[(5-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


5-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 5-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 5-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 5-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

2-Hydroxyundecanoylcarnitine

3-[(2-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


2-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 2-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 2-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 2-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

9-Hydroxyundecanoylcarnitine

3-[(9-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


9-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 9-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 9-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 9-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

6-Hydroxyundecanoylcarnitine

3-[(6-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


6-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 6-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 6-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 6-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

7-Hydroxyundecanoylcarnitine

3-[(7-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


7-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 7-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 7-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 7-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

10-Hydroxyundecanoylcarnitine

3-[(10-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


10-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 10-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 10-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 10-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

4-Hydroxyundecanoylcarnitine

3-[(4-hydroxyundecanoyl)oxy]-4-(trimethylazaniumyl)butanoate

C18H35NO5 (345.2515)


4-Hydroxyundecanoylcarnitine is an acylcarnitine. More specifically, it is an 4-hydroxyundecanoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. 4-Hydroxyundecanoylcarnitine is therefore classified as a medium chain AC. As a medium-chain acylcarnitine 4-Hydroxyundecanoylcarnitine is somewhat less abundant than short-chain acylcarnitines. These are formed either through esterification with L-carnitine or through the peroxisomal metabolism of longer chain acylcarnitines (PMID: 30540494). Many medium-chain acylcarnitines can serve as useful markers for inherited disorders of fatty acid metabolism. Carnitine octanoyltransferase (CrOT, EC:2.3.1.137) is responsible for the synthesis of all medium-chain (MCAC, C5-C12) and medium-length branched-chain acylcarnitines in peroxisomes (PMID: 10486279). The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

5-Nitroxystearic acid

2-(3-Carboxypropyl)-2-tridecyl-4,4-dimethyl-3-oxazolidinyloxyl

C18H35NO5 (345.2515)


   

Himbacine

4-[2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3H-naphtho[2,3-c]furan-1-one

C22H35NO2 (345.2668)


   

1-Piperidinepropanol, alpha-cyclohexyl-4-(3-hydroxyphenyl)-3,4-dimethyl-

1-(3-Hydroxy-3-cyclohexylpropyl)-4-(3-hydroxyphenyl)-3,4-dimethyl-1-piperidine

C22H35NO2 (345.2668)


   

N-(2-Hydroxyethyl)icosa-2,4,6,8,10-pentaenamide

N-(2-Hydroxyethyl)icosa-2,4,6,8,10-pentaenimidate

C22H35NO2 (345.2668)


   

Broussonetinine B

Broussonetinine B

C18H35NO5 (345.2515)


   

Funtumafrine C

Funtumafrine C

C23H39NO (345.3031)


   

Dihydroatisine

F-Dihydroatisine

C22H35NO2 (345.2668)


   
   

Daphnezomine M

Daphnezomine M

C22H35NO2 (345.2668)


   

paxdaphnidine B

paxdaphnidine B

C22H35NO2 (345.2668)


   

batzellaside C

batzellaside C

C19H39NO4 (345.2879)


   

(9Z)-octadec-9-ynoic acid piperidine

(9Z)-octadec-9-ynoic acid piperidine

C23H39NO (345.3031)


   

dimethylamino-3beta-pregnane-20-one|Dimethylfuntumine

dimethylamino-3beta-pregnane-20-one|Dimethylfuntumine

C23H39NO (345.3031)


   

ACMC-20n42w

ACMC-20n42w

C23H39NO (345.3031)


   

2-amino-1,3,4-eicosanetriol

2-amino-1,3,4-eicosanetriol

C20H43NO3 (345.3243)


   
   
   

curvularide A

curvularide A

C18H35NO5 (345.2515)


   

Kurchiphyllamine

Kurchiphyllamine

C22H35NO2 (345.2668)


   

calyciphylline F

calyciphylline F

C22H35NO2 (345.2668)


   

MLS001074064-01!Bentyl

MLS001074064-01!Bentyl

C19H36ClNO2 (345.2434)


   

N-propylarachidonoylamide

N-propyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C23H39NO (345.3031)


   

N-isopropylarachidonoylamide

N-isopropyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C23H39NO (345.3031)


   

Anandamide (20:5, n-3)

N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-ethanolamine

C22H35NO2 (345.2668)


   

2,4,12-Octadecatrienoic acid piperidide

(2E,4Z,12E)-1-(piperidin-1-yl)octadeca-2,4,12-trien-1-one

C23H39NO (345.3031)


   

Macamide B

N-benzylhexadecanamide

C23H39NO (345.3031)


Macamide B (N-Benzylhexadecanamide; Macamide 1) is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH). N-Benzylpalmitamide is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH). N-Benzylpalmitamide is a macamide isolated from Lepidium meyenii, acts as an inhibitor of fatty acid amide hydrolase (FAAH).

   

NA 23:4

N-isopropyl-5Z,8Z,11Z,14Z-eicosatetraenoyl amine

C23H39NO (345.3031)


   

NAE 20:5

N-(5Z,8Z,11Z,14Z,17Z-eicosapentaenoyl)-ethanolamine

C22H35NO2 (345.2668)


   
   

dehydroabietylamine acetate

dehydroabietylamine acetate

C22H35NO2 (345.2668)


   

N-Hexadecylbenzamide

N-Hexadecylbenzamide

C23H39NO (345.3031)


   

Dicyclomine hydrochloride

Dicyclomine hydrochloride

C19H36ClNO2 (345.2434)


C78272 - Agent Affecting Nervous System > C66880 - Anticholinergic Agent > C29704 - Antimuscarinic Agent D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics D018377 - Neurotransmitter Agents > D018678 - Cholinergic Agents > D018680 - Cholinergic Antagonists C78272 - Agent Affecting Nervous System > C29698 - Antispasmodic Agent Dicyclomine hydrochloride is a potent and orally active muscarinic cholinergic receptors antagonist. Dicyclomine hydrochloride shows high affinity for muscarinic M1 receptor subtype (Ki=5.1 nM) and M2 receptor subtype (Ki=54.6 nM) in brush-border membrane and basal plasma membranes, respectively[1]. Dicyclomine is an antispasmodic agent and relieves smooth muscle spasm of the gastrointestinal tract in vivo[2].

   

7-Ethano-1H-isoindole-1, 3(2H)-dion, 2-(2-ethylhexyl)-3a,4,7,7a-tetrahydro-4-methyl-7-(1-methylethy4

7-Ethano-1H-isoindole-1, 3(2H)-dion, 2-(2-ethylhexyl)-3a,4,7,7a-tetrahydro-4-methyl-7-(1-methylethy4

C22H35NO2 (345.2668)


   

4-(3-(Piperidin-1-yl)propoxy)phenylboronic acid, pinacol ester

4-(3-(Piperidin-1-yl)propoxy)phenylboronic acid, pinacol ester

C20H32BNO3 (345.2475)


   

tert-Butyl 4-(1-benzylpyrrolidin-3-yl)piperazine-1-carboxylate

tert-Butyl 4-(1-benzylpyrrolidin-3-yl)piperazine-1-carboxylate

C20H31N3O2 (345.2416)


   

trimethyloleylammonium chloride

trimethyloleylammonium chloride

C21H44ClN (345.3162)


   

N-(2-hydroxyethyl)-N-(2-hydroxytetradecyl)beta-alanine

N-(2-hydroxyethyl)-N-(2-hydroxytetradecyl)beta-alanine

C19H39NO4 (345.2879)


   

N1,N4-Bis-Boc-spermidine

N1,N4-Bis-Boc-spermidine

C17H35N3O4 (345.2627)


   

N1,N5-Bis-Boc-spermidine

N1,N5-Bis-Boc-spermidine

C17H35N3O4 (345.2627)


   

(2S,3S,4R)-2-aminoicosane-1,3,4-triol

(2S,3S,4R)-2-aminoicosane-1,3,4-triol

C20H43NO3 (345.3243)


   

8-Hydroxyundecanoylcarnitine

8-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

5-Hydroxyundecanoylcarnitine

5-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

2-Hydroxyundecanoylcarnitine

2-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

9-Hydroxyundecanoylcarnitine

9-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

6-Hydroxyundecanoylcarnitine

6-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

7-Hydroxyundecanoylcarnitine

7-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

4-Hydroxyundecanoylcarnitine

4-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

N-eicosapentaenoylethanolamine

N-eicosapentaenoylethanolamine

C22H35NO2 (345.2668)


   

10-Hydroxyundecanoylcarnitine

10-Hydroxyundecanoylcarnitine

C18H35NO5 (345.2515)


   

(+)-Himbacine

(+)-Himbacine

C22H35NO2 (345.2668)


D018373 - Peripheral Nervous System Agents > D001337 - Autonomic Agents > D010276 - Parasympatholytics

   

(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoate

(7Z,10Z,13R,14E,16Z,19Z)-13-hydroxydocosapentaenoate

C22H33O3- (345.243)


A polyunsaturated fatty acid anion that is the conjugate base of (13R)-hydroxy-(7Z,10Z,14E,16Z,19Z)-docosapentaenoic acid, arising from deprotonation of the carboxylic acid group; major species at pH 7.3. It is an intermediate in 13-series resolvins biosynthesis from DPA (omega-3).

   

(7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-7,10,13,16-tetraenoate

(7Z,10Z,13Z,16Z)-18-(3-ethyloxiran-2-yl)octadeca-7,10,13,16-tetraenoate

C22H33O3- (345.243)


   

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosa-4,7,10,13,16-pentaenoate

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosa-4,7,10,13,16-pentaenoate

C22H33O3- (345.243)


   

(7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-7,10,13-trienoate

(7Z,10Z,13Z)-15-{3-[(2Z)-pent-2-en-1-yl]oxiran-2-yl}pentadeca-7,10,13-trienoate

C22H33O3- (345.243)


   

(7Z,10Z)-12-{3-[(2Z,5Z)-octa-2,5-dien-1-yl]oxiran-2-yl}dodeca-7,10-dienoate

(7Z,10Z)-12-{3-[(2Z,5Z)-octa-2,5-dien-1-yl]oxiran-2-yl}dodeca-7,10-dienoate

C22H33O3- (345.243)


   

(7Z)-9-{3-[(2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl]oxiran-2-yl}non-7-enoate

(7Z)-9-{3-[(2Z,5Z,8Z)-undeca-2,5,8-trien-1-yl]oxiran-2-yl}non-7-enoate

C22H33O3- (345.243)


   

2-{[1,1-bi(cyclohexyl)-1-ylcarbonyl]oxy}-N,N-diethylethanaminium chloride

2-{[1,1-bi(cyclohexyl)-1-ylcarbonyl]oxy}-N,N-diethylethanaminium chloride

C19H36ClNO2 (345.2434)


   

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosa-8,10,13,16,19-pentaenoate

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosa-8,10,13,16,19-pentaenoate

C22H33O3- (345.243)


   

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosa-4,7,10,12,16-pentaenoate

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosa-4,7,10,12,16-pentaenoate

C22H33O3- (345.243)


   

N-(omega-hydroxyacyl)-sphingosine

N-(omega-hydroxyacyl)-sphingosine

C19H39NO4 (345.2879)


   

Diamino-(carboxymethyl)-[3-(dodecanoylamino)propyl]azanium

Diamino-(carboxymethyl)-[3-(dodecanoylamino)propyl]azanium

C17H37N4O3+ (345.2866)


   

(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine

(5Z,8Z,11Z,14Z,17Z)-icosapentaenoylethanolamine

C22H35NO2 (345.2668)


An N-acylethanolamine 20:5 that is the ethanolamide of (5Z,8Z,11Z,14Z17Z)-eicosapentaenoic acid.

   

3-hydroxyundecanoyl carnitine

3-hydroxyundecanoyl carnitine

C18H35NO5 (345.2515)


   

N-propyl arachidonoyl amine

N-propyl arachidonoyl amine

C23H39NO (345.3031)


   

(7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoate

(7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,10Z,13Z,16Z)-19,20-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3

   

(7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoate

(7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,10Z,13Z,19Z)-16,17-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoate

(7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,10Z,16Z,19Z)-13,14-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoate

(7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (7Z,13Z,16Z,19Z)-10,11-epoxydocosatetraenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate

(4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoate

C22H33O3 (345.243)


A hydroxydocosapentaenoate that is the conjugate base of (4Z,7Z,10Z,12E,14S,16Z)-14-hydroxydocosapentaenoic acid, arising from deprotonation of the carboxy group; major species at pH 7.3.

   

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosapentaenoate

(8E,10Z,13Z,16Z,19Z)-7-hydroxydocosapentaenoate

C22H33O3 (345.243)


A hydroxydocosahexaenoate that is the conjugate base of (8E,10Z,13Z,16Z,19Z)-docosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoate

(4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoate

C22H33O3 (345.243)


A docosanoid anion that is the conjugate base of (4Z,7Z,10Z,13Z,16Z)-20-hydroxydocosapentaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

Sphingosine (t20:0)

SPH(t20:0)

C20H43NO3 (345.3243)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved

   

NA-Amylamine 18:4(6Z,9Z,12Z,15Z)

NA-Amylamine 18:4(6Z,9Z,12Z,15Z)

C23H39NO (345.3031)


   

Eicosapentenoyl-EA

Eicosapentenoyl-EA

C22H35NO2 (345.2668)


   
   

LY255582

LY255582

C22H35NO2 (345.2668)


LY255582 is a pan-opioid antagonist and has high affinity for mu, delta, and kappa receptors (Ki: 0.4 nM, 5.2, 2.0 nM respectively). LY255582 can decrease food intake and body weight. LY255582 can be used for the research of obesity[1][2][3][4].

   

1-(piperidin-1-yl)octadec-9-en-12-yn-1-one

1-(piperidin-1-yl)octadec-9-en-12-yn-1-one

C23H39NO (345.3031)


   

3-{14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoic acid

3-{14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl}propanoic acid

C22H35NO2 (345.2668)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

C18H35NO5 (345.2515)


   

(2e,4e,12z)-1-(piperidin-1-yl)octadeca-2,4,12-trien-1-one

(2e,4e,12z)-1-(piperidin-1-yl)octadeca-2,4,12-trien-1-one

C23H39NO (345.3031)


   

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

13-[3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

C18H35NO5 (345.2515)


   

methyl 3-[(1s,2s,3r,7s,10r,12r,13s)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

methyl 3-[(1s,2s,3r,7s,10r,12r,13s)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

C22H35NO2 (345.2668)


   

13-methyl-n-(2-phenylethyl)tetradecanimidic acid

13-methyl-n-(2-phenylethyl)tetradecanimidic acid

C23H39NO (345.3031)


   

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

C18H35NO5 (345.2515)


   

(1s,2s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

(1s,2s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

(2e,4e,14e)-1-(piperidin-1-yl)octadeca-2,4,14-trien-1-one

(2e,4e,14e)-1-(piperidin-1-yl)octadeca-2,4,14-trien-1-one

C23H39NO (345.3031)


   

(1s,2s,4r,6r,7r,10r,11s)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

(1s,2s,4r,6r,7r,10r,11s)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C23H39NO (345.3031)


   

1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

1-[1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

C23H39NO (345.3031)


   

methyl 3-{13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl}propanoate

methyl 3-{13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl}propanoate

C22H35NO2 (345.2668)


   

(6e)-2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

(6e)-2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

C22H35NO2 (345.2668)


   

1-[7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

C23H39NO (345.3031)


   

1-[(1s,3as,3br,5as,7r,9ar,9br,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

1-[(1s,3as,3br,5as,7r,9ar,9br,11as)-7-(dimethylamino)-9a,11a-dimethyl-tetradecahydro-1h-cyclopenta[a]phenanthren-1-yl]ethanone

C23H39NO (345.3031)


   

(1s,2s,4s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

(1s,2s,4s,6r,7s,10r,11r)-13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

n-benzylhexadecanimidic acid

n-benzylhexadecanimidic acid

C23H39NO (345.3031)


   

1-(piperidin-1-yl)octadeca-2,4,12-trien-1-one

1-(piperidin-1-yl)octadeca-2,4,12-trien-1-one

C23H39NO (345.3031)


   

methyl 3-[(1r,2r,3s,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

methyl 3-[(1r,2r,3s,10s,12s,13r)-13-isopropyl-1-methyl-11-azapentacyclo[8.5.0.0²,¹².0³,⁷.0⁷,¹¹]pentadecan-2-yl]propanoate

C22H35NO2 (345.2668)


   

(2e,4e,14z)-1-(piperidin-1-yl)octadeca-2,4,14-trien-1-one

(2e,4e,14z)-1-(piperidin-1-yl)octadeca-2,4,14-trien-1-one

C23H39NO (345.3031)


   

(2r,3s,4s,6s)-2-(hydroxymethyl)-6-(2-hydroxytridecyl)piperidine-3,4-diol

(2r,3s,4s,6s)-2-(hydroxymethyl)-6-(2-hydroxytridecyl)piperidine-3,4-diol

C19H39NO4 (345.2879)


   

(2e,4r,5s,6s,8r)-4,5,8-trihydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-4,6-dimethyldec-2-enimidic acid

(2e,4r,5s,6s,8r)-4,5,8-trihydroxy-n-[(2s,3s)-1-hydroxy-3-methylpentan-2-yl]-4,6-dimethyldec-2-enimidic acid

C18H35NO5 (345.2515)


   

(3s,3ar,4r,8ar,9as)-4-[(1e)-2-[(2s,6r)-1,6-dimethylpiperidin-2-yl]ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

(3s,3ar,4r,8ar,9as)-4-[(1e)-2-[(2s,6r)-1,6-dimethylpiperidin-2-yl]ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

C22H35NO2 (345.2668)


   

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-4-one

C18H35NO5 (345.2515)


   

1-(piperidin-1-yl)octadeca-2,4,14-trien-1-one

1-(piperidin-1-yl)octadeca-2,4,14-trien-1-one

C23H39NO (345.3031)


   

2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

2-(dimethylamino)-1-(4-hydroxyphenyl)-8,10-dimethyldodec-6-en-3-one

C22H35NO2 (345.2668)


   

4,5,8-trihydroxy-n-(1-hydroxy-3-methylpentan-2-yl)-4,6-dimethyldec-2-enimidic acid

4,5,8-trihydroxy-n-(1-hydroxy-3-methylpentan-2-yl)-4,6-dimethyldec-2-enimidic acid

C18H35NO5 (345.2515)


   

(1s,3as,3br,5as,9as,9bs,11as)-1-[(1r)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

(1s,3as,3br,5as,9as,9bs,11as)-1-[(1r)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

C23H39NO (345.3031)


   

13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

13-(2-hydroxyethyl)-11-methyl-5-methylidene-13-azapentacyclo[9.3.3.2⁴,⁷.0¹,¹⁰.0²,⁷]nonadecan-6-ol

C22H35NO2 (345.2668)


   

4-[(1e)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

4-[(1e)-2-(1,6-dimethylpiperidin-2-yl)ethenyl]-3-methyl-decahydro-3h-naphtho[2,3-c]furan-1-one

C22H35NO2 (345.2668)


   

(1s,3as,3br,5as,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

(1s,3as,3br,5as,9as,9bs,11as)-1-[(1s)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-tetradecahydrocyclopenta[a]phenanthren-7-one

C23H39NO (345.3031)


   

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

13-[(2r,3r,4s,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

C18H35NO5 (345.2515)


   

3-[(1s,2r,3r,7r,10s,11r,13s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

3-[(1s,2r,3r,7r,10s,11r,13s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

C22H35NO2 (345.2668)


   

3-[(1r,2r,7s,10r,13r,14s)-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoic acid

3-[(1r,2r,7s,10r,13r,14s)-14-isopropyl-1-methyl-12-azatetracyclo[8.6.0.0²,¹³.0³,⁷]hexadec-3-en-2-yl]propanoic acid

C22H35NO2 (345.2668)


   

(1s,3as,3bs,7s,9ar,9bs,11as)-1-[(1r)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

(1s,3as,3bs,7s,9ar,9bs,11as)-1-[(1r)-1-(dimethylamino)ethyl]-9a,11a-dimethyl-1h,2h,3h,3ah,3bh,4h,6h,7h,8h,9h,9bh,10h,11h-cyclopenta[a]phenanthren-7-ol

C23H39NO (345.3031)


   

3-[(1s,2r,7r,10s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

3-[(1s,2r,7r,10s,14r)-14-isopropyl-1-methyl-12-azapentacyclo[8.6.0.0²,¹³.0³,⁷.0⁷,¹¹]hexadecan-2-yl]propanoic acid

C22H35NO2 (345.2668)


   

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

13-[(2r,3r,4r,5r)-3,4-dihydroxy-5-(hydroxymethyl)pyrrolidin-2-yl]-1-hydroxytridecan-5-one

C18H35NO5 (345.2515)


   

(9z)-1-(piperidin-1-yl)octadec-9-en-12-yn-1-one

(9z)-1-(piperidin-1-yl)octadec-9-en-12-yn-1-one

C23H39NO (345.3031)